CERUTI, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 470
EU - Europa 213
AS - Asia 130
AF - Africa 9
OC - Oceania 7
Totale 829
Nazione #
US - Stati Uniti d'America 468
CN - Cina 79
SE - Svezia 47
IE - Irlanda 27
DE - Germania 25
IT - Italia 23
FI - Finlandia 19
SG - Singapore 18
AT - Austria 17
UA - Ucraina 17
FR - Francia 16
KR - Corea 15
SN - Senegal 9
GB - Regno Unito 8
AU - Australia 7
VN - Vietnam 7
PL - Polonia 6
TW - Taiwan 6
NL - Olanda 3
BE - Belgio 2
CA - Canada 2
HU - Ungheria 2
JP - Giappone 2
EE - Estonia 1
HK - Hong Kong 1
IN - India 1
UZ - Uzbekistan 1
Totale 829
Città #
Chandler 76
Houston 48
Beijing 47
Fairfield 34
Dearborn 28
Ann Arbor 27
Dublin 27
Jacksonville 18
Ashburn 17
Vienna 17
Woodbridge 17
Wilmington 15
Nyköping 14
Cambridge 13
Seattle 13
Pisa 12
Villeurbanne 12
Medford 11
Singapore 10
Princeton 8
Dong Ket 7
Munich 7
Washington 7
Taipei 6
Warsaw 6
Boardman 4
Guangzhou 4
Nanjing 4
Boston 3
San Diego 3
Seoul 3
Tampa 3
Xian 3
Brussels 2
Budapest 2
Catania 2
Chapel Hill 2
Clayton 2
Düsseldorf 2
Groningen 2
Helsinki 2
Kunming 2
Lanzhou 2
Melbourne 2
Monash 2
Norwalk 2
Phoenix 2
Shanghai 2
Shenyang 2
Silver Spring 2
Torino 2
Toronto 2
Verona 2
Wuhan 2
Aalen 1
Bloomington 1
Changsha 1
Chengdu 1
Clifton 1
Falls Church 1
Farmington 1
Fremont 1
Hebei 1
Heidelberg 1
Hong Kong 1
Kävlinge 1
Langenfeld 1
Los Angeles 1
Milan 1
New Delhi 1
Ningbo 1
Notre Dame 1
Nuremberg 1
Philadelphia 1
San Severino Marche 1
Shaoxing 1
Tokai 1
Upper Marlboro 1
Utrecht 1
Wilmslow 1
Totale 592
Nome #
Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells 204
Three are better than one: plasminogen receptors as cancer theranostic targets. 139
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma associated antigen 132
THE BLOCKADE OF PLASMINOGEN-ALPHA-ENOLASE INTERACTION INHIBITS THE INVASION OF PANCREATIC CANCER CELLS. 91
The ectoenzyme α-enolase, a pancreatic adenocarcinoma (PDAC)-associated antigen, elicits both in vitro and in vivo T cell responses 76
CCL16 chemokine optimizes tumor antigen presentation by inducing a new human dendritic cell maturation stage. “9th 74
Lactoferrin, a Major Defense Protein of innate immunity, is a novel maturation factor for human dendritic cells 71
CCL16 enhances the CD8+ and CD4+ T cell reactivity to human HER-2 elicited by dendritic cells loaded with rat ortholog HER-2 66
Totale 853
Categoria #
all - tutte 2.229
article - articoli 0
book - libri 0
conference - conferenze 701
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020171 0 5 11 17 12 53 18 7 13 13 6 16
2020/202192 6 3 12 4 11 11 5 4 8 7 6 15
2021/202295 5 6 3 7 4 5 8 6 0 3 25 23
2022/2023176 14 14 6 20 15 47 10 9 23 4 9 5
2023/202458 9 9 8 4 5 9 0 0 0 3 7 4
2024/202511 5 6 0 0 0 0 0 0 0 0 0 0
Totale 853